← back to search

Sigrun Smola

Helmholtz Institute for Pharmaceutical Research Saarland · DE
Area of research
Epidemiology · Oncology
Research interest
Research interests include Cervical Cancer and HPV Research, Genital Health and Disease, Cytokine Signaling Pathways and Interactions, and Cancer Immunotherapy and Biomarkers.
h-index
30
citations
3,554
works
220
NIH funding
primary concept
Medicine
email

Recent publications

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study
The Lancet Rheumatology 2022cited by 68position: middledoi
TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study
International Journal of Infectious Diseases 2022cited by 37position: middledoi
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
Nature Communications 2021cited by 93position: middledoi
German evidence and consensus‐based (S3) guideline: Vaccination recommendations for the prevention of HPV‐associated lesions
JDDG Journal der Deutschen Dermatologischen Gesellschaft 2021cited by 18position: middledoi
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
European Journal of Immunology 2021cited by 14position: middledoi
Evidenz‐ und konsensbasierte (S3) Leitlinie: Impfprävention HPV‐assoziierter Neoplasien
JDDG Journal der Deutschen Dermatologischen Gesellschaft 2021cited by 7position: middledoi
Going beyond clinical routine in SARS-CoV-2 antibody testing - A multiplex corona virus antibody test for the evaluation of cross-reactivity to endemic coronavirus antigens
medRxiv 2020cited by 13position: middledoi
Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution
Cell Host & Microbe 2018cited by 82position: middledoi
Impfprävention HPV-assoziierter Neoplasien
Laryngo-Rhino-Otologie 2014cited by 12position: middledoi
Vaccination against HPV-Associated Neoplasias
Geburtshilfe und Frauenheilkunde 2014cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Reuben S. Harris · Howard Hughes Medical Institute1 papers (2018–2018) · 1 papers (2021–2021)Mayur Ramesh · Henry Ford Health System1 papers (2018–2018)Christopher B. Buck · Center for Cancer Research1 papers (2018–2018)Peter Fitzgerald · Center for Cancer Research1 papers (2018–2018) · 1 papers (2021–2021) · 1 papers (2018–2018) · 1 papers (2021–2021)Efrem S. Lim · Arizona State University1 papers (2018–2018) · 1 papers (2021–2021)Robert Bals · Sorbonne Université1 papers (2021–2021) · 1 papers (2021–2021)Eileen M. Geoghegan · Center for Cancer Research1 papers (2018–2018) · 1 papers (2021–2021) · 1 papers (2021–2021)Alberto Peretti · Center for Cancer Research1 papers (2018–2018)Marbin Pineda · Center for Cancer Research1 papers (2018–2018)Stefan Lohse · Leibniz-Institute for New Materials1 papers (2018–2018)Yvonne Bewarder · Universitätsklinikum des Saarlandes1 papers (2021–2021) · 1 papers (2018–2018)